• Liquidia to Report Third Quarter 2022 Financial Results on November 8, 2022

    Источник: Nasdaq GlobeNewswire / 01 ноя 2022 06:45:16   America/New_York

    MORRISVILLE, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its third quarter 2022 financial results on Tuesday, November 8, 2022. The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss financial results and provide a corporate update.

    The live call may be accessed by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and entering the conference code: 7467713. A webcast of the call will be available and archived for 30 days on Liquidia’s website at https://liquidia.com/index.php/investors/events-and-presentations.

    About Liquidia Corporation
    Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA™ (treprostinil) inhalation powder, an investigational, inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH). Liquidia PAH provides the commercialization for rare disease pharmaceutical products, such as generic Treprostinil Injection. For more information, please visit www.liquidia.com.

    Contact Information for Media & Investors
    Jason Adair
    Senior Vice President, Corporate Development and Strategy
    919.328.4400
    jason.adair@liquidia.com


    Primary Logo

Опубликовать